Search Results 8931-8940 of 34000 for oral

  1. Robotic surgery - Doctors & Departments - Mayo Clinic

    ... Oral and throat cancer, Salivary gland cancer, Mouth cancer, Thyroid cancer, Head and neck cancer, Melanoma, Tonsil cancer, Skin cancer, Squamous cell ...

  2. Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery - Mayo Clinic

    No patients receiving systemic corticosteroids (either intravenous [IV] or oral steroids, excluding inhalers or low-dose hormone replacement therapy) within 1 ...

  3. Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer - Mayo Clinic

    Able to take oral medications. Willing and able to comply with scheduled visits, treatment plan, laboratory tests and other study procedures. Female ...

  4. Clinical trials - Oncology (Medical)

    ... oral chemotherapy regimens. Finally, this study will be the first to track the outcomes of subjects with disseminated B-cell Lymphoblastic Leukemia (B LLy) ...

  5. Robotic surgery - Doctors & Departments - Mayo Clinic

    ... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...

  6. Treatment of recurrent CDI: Examining the efficacy and safety of standardized live biotherapeutics as microbiota restoration therapies - Mayo Clinic

    Feuerstadt P, et al. SER-109, an oral microbiome therapy for recurrent Clostridioides difficile infection. New England Journal of Medicine. 2022;386:220. Refer ...

  7. Thyroid cancer - Doctors and departments - Mayo Clinic

    ... Oral and thro...at cancer, Thyroid cancer, Head and neck cancer, Skull base tumor, Salivary gland tumor, Nasopharyngeal carcinoma, Laryngeal cancer ...

  8. Updates in interstitial lung disease: Current facets of anti-fibrotic therapy - Mayo Clinic

    Current medical management involves two oral anti-fibrotic agents: nintedanib and pirfenidone. Nintedanib is a triple tyrosine kinase inhibitor acting at ...

  9. Publications - Timothy D. Malouff, M.D. - Mayo Clinic

    Oral Oncol. 2025 Nov; 170:107647 Epub 2025 Oct 02. View PubMed; Sabharwal Kennedy, Lin Anna, Cook Katie, Malouff Tim, Ko Stephen, May Byron, Tolaymat Leila ...

  10. Minimally invasive surgery - Doctors & Departments - Mayo Clinic

    ... Oral and throat cancer, Adenocarcinoma, Tongue base cancer, Oropharyngeal cancer. Show more areas of focus for Eric J. Moore, M.D.. Adyr A ...